IMMUNIC THERAPEUTICS

Immunic, Inc. is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The company is developing three small molecule products: its lead development program, IMU-838, a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH and exhibits a host-based antiviral effect, is currently being developed as a treatment option f... or multiple sclerosis, ulcerative colitis, Crohn's disease, and primary sclerosing cholangitis. IMU-935, a selective inverse agonist of the transcription factor RORγt, is targeted for development in psoriasis, castration-resistant prostate cancer and Guillain-Barré syndrome. IMU-856, which targets the restoration of the intestinal barrier function, is targeted for development in diseases involving bowel barrier dysfunction.

#SimilarOrganizations #People #Financial #Website #More

IMMUNIC THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Life Science Medical Therapeutics

Founded:

2016-04-01

Address:

New York, New York, United States

Country:

United States

Website Url:

http://www.imux.com

Total Employee:

11+

Status:

Active

Contact:

+4989208047700

Email Addresses:

[email protected]

Total Funding:

224.36 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Office 365 Mail Person Schema CKEditor Comodo SSL

Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

aulos-bioscience-logo

Aulos Bioscience

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

checkmate-pharmaceuticals-logo

Checkmate Pharmaceuticals

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

Current Advisors List

not_available_image

Duane Nash Chairman of the Board of Directors @ Immunic Therapeutics
Board_member
2019-04-01

jörg-neermann_image

Jörg Neermann Board Member @ Immunic Therapeutics
Board_member
2019-01-01

Current Employees Featured

hella-kohlhof_image

Hella Kohlhof
Hella Kohlhof Chief Scientific Officer @ Immunic Therapeutics
Chief Scientific Officer
2017-01-01

daniel-vitt_image

Daniel Vitt
Daniel Vitt CEO, President and Director @ Immunic Therapeutics
CEO, President and Director

andreas-muehler_image

Andreas Muehler
Andreas Muehler Chief Medical Officer @ Immunic Therapeutics
Chief Medical Officer
2016-04-01

not_available_image

Duane Nash
Duane Nash Executive Chairman @ Immunic Therapeutics
Executive Chairman
2020-04-01

darius-jean-namdjou_image

Darius-Jean Namdjou
Darius-Jean Namdjou Head of Regulatory Affairs & Pharmacovigilance @ Immunic Therapeutics
Head of Regulatory Affairs & Pharmacovigilance
2021-08-01

Founder

andreas-muehler_image

Andreas Muehler

daniel-vitt_image

Daniel Vitt

hella-kohlhof_image

Hella Kohlhof

manfred-groppel_image

Manfred Groppel

Stock Details

Company's stock symbol is NASDAQ:IMUX

Acquisitions List

Date	Company	Article	Price
2019-04-12	Vital Therapies	Vital Therapies acquired by Immunic Therapeutics	N/A

Investors List

german-federal-ministry-of-education-and-research-bmbf_image

Official Site Inspections

http://www.imux.com Semrush global rank: 2.83 M Semrush visits lastest month: 5.72 K

Host Informations
Whois Informations

Loading ...